2020-2027 Analysis and Review Acetylcysteine Market
Acetylcysteine Market By Treatment (Acetaminophen Overdose, Chronic Obstructive Pulmonary Disease and Dietary Supplement), By End Users (Hospital & Clinics, Ambulatory Surgical Centers and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027
The acetylcysteine market was valued at USD 537.2 Mn by 2019. As per the latest research citings presented by the World Health Organization (WHO), it is anticipated that chronic obstructive pulmonary disease will be the 3rd largest cause of death throughout the globe by 2030. Rising prevalence of acetaminophen overdose throughout the globe will further bolster the market growth.
Acetylcysteine is basically a derivative of the cysteine molecule with an acetyl group attached to its amino acid. N-acetyl cysteine is the prodrug of cysteine which is absorbed via the intestines and is vital in replenishing the glutathione reserves of the liver. It is enlisted in the World Health Organization (WHO) list of essential medicines.
The major segments related to the acetylcysteine market are:
By Treatment (2017–2027; US$ Mn)
Acetaminophen Overdose
Chronic Pulmonary Obstructive Disease (COPD)
Dietary Supplement
By End Users (2017–2027; US$ Mn)
Hospital and Clinics
Ambulatory Surgical Centers
Others
Geography Segment (2017–2027; US$ Mn)
North America
United States
Canada
Europe
United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe
Asia Pacific
China
Japan
Rest of Asia Pacific
Latin America (LATAM)
Brazil
Mexico
Rest of Latin America
Middle East and Africa (MEA)
GCC
Rest of MEA
Justification for study?
Report gist?
The study includes the profiles of major market players with a significant global and regional presence along with top company positioning.
Significant customers?
Segment Analysis
Acetaminophen overdose in presently representing the largest market share in the treatment segment for acetylcysteine market. The major factor responsible for its market growth is the constant rise in patients suffering from fever associated with infectious disease worldwide. Acetaminophen overdose is associated with non- compliance to doctor’s prescription and in few cases gross negligence with the drug posology pertaining to acetaminophen. Its primary objective is to maintain and replenish the glutathione reserves of the liver and promote the non-toxic metabolism of acetaminophen. Chronic obstructive pulmonary disease (COPD) is a collective term used for the disease of the lower respiratory tract such as chronic bronchitis and emphysema. The clinical manifestation associated with COPD is shortness in breath due to excess secretion of mucus. Acetylcysteine inhalation is beneficial reducing the adhesiveness and viscosity of the mucus and promotes its expulsion from the lower respiratory tract.
Hospitals and clinics are leading the end-user segment for the acetylcysteine market. Patients suffering from chronic bronchitis and emphysema need to be immediately admitted to the intensive care unit to stabilize their condition. Intravenous or inhalation dose of acetylcysteine needs to be started immediately as the treatment regimen. Ambulatory surgical centers have gained prominence in the developed regions owing to its ability to treat acetaminophen overdose in patients residing in remote locations.
North America currently dominating the geography segment for the acetylcysteine market. As per the latest research citings brought forward by the Center for Disease Control and Prevention (CDC) the death rate of chronic pulmonary obstructive disease in the United States is approximately 44.3 per 100,000 people each year. Furthermore, the presence of key players such as Fresenius Kabi USA, LLC, Arbor Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., Sandoz, Inc., etc further propel the market growth in the region. Europe is placed in the 2nd position in the regional segment on account of the favorable reimbursement scenario for acetylcysteine used for the treatment of acute liver failure in the region. Asia Pacific is anticipated to be the fastest-growing regional segment in the acetylcysteine market. Rising prevalence of acetaminophen overdose on account of noncompliance to physician’s prescription and flourishing generic drugs market together determine the acetylcysteine market growth in the region.
$4,600 | |
$6,600 | |
$13,200 |
Request customization |
Get market alerts |
Ask for regional data |
Ask for country-specific data |